Bio-defense plays

Companies involved in biological and chemical warfare defense research lost some of their luster last week, as 12 out of the 21 companies in that field lost value on the week. Nonetheless, most of the companies remain up sharply from their pre-terrorist valuations: All but four have traded up since Sept. 10, with seven